CAPTRUST FINANCIAL ADVISORS - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$9,100
-32.1%
20,0000.0%0.00%
Q2 2023$13,400
+55.8%
20,0000.0%0.00%
Q1 2023$8,600
-28.3%
20,0000.0%0.00%
Q3 2022$12,000
-25.0%
20,0000.0%0.00%
Q2 2022$16,000
-23.8%
20,0000.0%0.00%
Q1 2022$21,000
+16.7%
20,0000.0%0.00%
Q4 2021$18,000
-55.0%
20,0000.0%0.00%
Q3 2021$40,000
-7.0%
20,0000.0%0.00%
Q2 2021$43,000
+34.4%
20,000
+42.9%
0.00%
Q1 2021$32,000
+77.8%
14,000
+40.0%
0.00%
Q4 2020$18,00010,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders